Roger Whiteside, Chief Executive at Greggs said:

“Following the successful implementation of Natasha’s Law, we are proud to support The Natasha Allergy Research Foundation in its mission to Make Allergy History and the NATASHA Trial which gives new hope to people living with food allergies, many of whom will be our customers.”

Sarah Bradbury, Group Quality Director, Tesco, said:

“Tesco is really proud to support research into food allergies by helping raise funds and awareness through sales from our Free From range. It’s wonderful to see that donations will go directly towards the Foundation’s first significant clinical trial into allergy management.”

Andrew Kenny, UK managing director of Just Eat, said:

"We take food safety and allergens extremely seriously so I'm delighted that Just Eat has been able to play a part in this pioneering trial, which could be revolutionary for those who experience food allergies. We will continue to use our scale and influence to raise standards across the sector and remain hopeful that food allergies will become history through the amazing work of the Natasha foundation.”

Matt Hood, Co-op’s Chief Commercial Officer, said:

“The Natasha Foundation are helping so many people living with food allergies through their critical research. We’re proud to be their charity partner and through the amazing support of our 2,600 food stores and the backing of our customers and members, we have already raised vital funds for the charity and moved one step closer to reaching our goal of raising £100,000 by 2023.”

David Scott, Morrisons Director of Corporate Affairs, said:

“Morrisons is proud to work with Nadim and Tanya in their mission to make allergy history. We know that many of our customers live with a food allergy and are delighted to support this important research.”

KFC UK & Ireland’s Chief Corporate Affairs and Sustainability Officer, Jenny Packwood:

"KFC is hugely proud to be supporting the first NATASHA trial. Like every hospitality business, we have a duty to look out for the increasing number of our guests who live with allergies. It's a daunting problem and it requires an ambitious, innovative response, so we're grateful to have had the opportunity to contribute to this pioneering research. We'll continue to cheer on Nadim, Tanya and the Natasha Allergy Research Foundation as they take us closer to making allergy history.”

Agust Gudmundsson, CEO at Bakkavor, said:

“We’re delighted and proud to be supporting the Natasha Allergy Research Foundation in their first ground-breaking NATASHA trial for people living with food allergies.

“Our partnership aims to raise greater awareness of the Foundation’s work, including this oral immunotherapy trial, which involves using everyday foods, to make allergy history and improve the quality of life for those living with allergy.”

Kate Stein, Sainsbury’s Director of Technical, said:

“Sainsbury’s has been at the forefront of understanding the challenges of food allergies, and as one of the UK’s leading supermarkets serving communities across the country, we are committed to offering our customers with food allergies and special dietary needs a range of delicious products they can safely enjoy. It’s why are proud to support the Natasha Allergy Research Foundation’s immunotherapy trial and play our part in eradicating food allergies.”

Andrew Selley, CEO of Bidfood/Bidcorp UK:

“We are incredibly proud to be a part of such important and potentially life-changing research that will not only help build confidence for those with severe allergies when eating out of home, but more importantly save countless lives. We are really looking forward to being a part of this exciting journey.”

Adrian Cook, Chief Operating Officer and Interim Managing Director, Costa Coffee UK&I, said:

“We’re delighted to be supporting such an important trial and helping the Natasha Foundation in its mission to make food allergies history. We take our responsibility to the safety and well-being of our consumers and team members extremely seriously, and believe that by working with the Foundation we can continue to improve our menu range and how we serve those with food allergies. Long-term we are excited to be a part of the solution, ensuring people can enjoy eating out of home without any concerns for food allergies.”

Elior UK CEO Catherine Roe said:

“We are delighted to support Tanya and Nadim in their important work changing the way we manage allergies and have therefore decided to join The Natasha Allergy Research Foundation as a Founding Partner. At Elior UK we fully understand the challenges and complexities of catering for people with food allergies and are keen to do all we can to limit those risks.

“We recognise that to eliminate or reduce life threatening reactions would make life so much safer and easier for those who live with these daunting threats and the new immunotherapy trial which is funded by the Foundation could be positively life changing for millions of people in the future. We are thrilled to be a part of this important mission to help make allergies history and ensure Natasha’s death wasn’t in vain”

Alasdair Murdoch, CEO of Burger King® UK:

“The Natasha Allergy Foundation is making exceptional efforts to drive change for those living with food allergies. Burger King® UK is committed to providing accurate information to ensure customers can make safe choices from our menu. We hope our contribution to the NATASHA trial helps facilitate life-changing research for those with severe allergies, making it possible for them to enjoy the food they love safely.”

Pano Christou, Chief Executive of Pret A Manger, said:

“Four years ago, we made a pledge to do everything we could to honour Natasha’s memory. Since then, we have been privileged to work with Tanya and Nadim as we have implemented the Pret Allergy Plan. This immunotherapy trial has the potential to be game-changing for people living with food allergies and intolerances, and it builds on the important work the Foundation has already delivered. Natasha’s legacy will always be a cornerstone of the way we work and how we serve customers at Pret A Manger, and we want to thank Nadim and Tanya for giving us the opportunity to participate in their mission in some way.”

Georgina Hall, Lidl GB’s Head of Communications and CSR said:

“Lidl GB is pleased to be working alongside Natasha’s Foundation and coming on board as a Founding Partner of The Natasha Clinical trial. This ground-breaking project has the potential to change millions of lives, and we’re excited to follow its progress over the next three years.”

Glenn Edwards, Managing Director of LEON restaurants*,said:

”At LEON we are incred- ibly proud to support The Natasha Allergy Research Foundation. The charity has made significant progress in raising awareness surrounding allergens and holding the food industry to account when it comes to providing clear and accurate information - this is something that's very important to us. The trial has the potential to prevent people having to take courses of medication which will not only be better for their health but will also be a huge benefit to the NHS. The LEON family wishes the very best of luck to all involved in the trial."

Andrew Hesketh, Head of Brand Development at Cooplands*, said:

“This is a really important clinical trial with a fantastic goal to see if those living with severe food aller- gies and most at risk of anaphylaxis can potentially take commonly available milk and peanut products under supervision as a treatment. The team at Cooplands looks forward to watching how this highly innovative trial progresses. More broadly, we felt it was important to support The Natasha Allergy Research Foundation, as it continues to help people, particularly the young, lead their lives to the full without the fear of a se- rious allergic food reaction.”

*Note: Both Cooplands and LEON are owned by EG Group.

Matthew Price, Uber Eats UK General Manager said:

“We are delighted to be working with the Natasha Allergy Research Foundation and supporting the Natasha Clinical trial. We hope that through this groundbreaking research, allergens really can become a thing of the past."